• Mashup Score: 0

    The European Association for the Study of Diabetes e.V. (EASD) Guidelines Oversight Committee (GOC) is pleased to announce an open call for Evidence Synthesis Teams based in European non-profit (preferably academic) institutions, with expertise in systematic reviews, meta-analyses, and evidence syntheses in the field of diabetes. This initiative is intended to facilitate the production of robust, reliable, and up-to-date guidelines that will shape best practice and optimize care in diabetes management.

    Tweet Tweets with this article
    • This initiative is intended to facilitate the production of robust, reliable, and up-to-date #guidelines that will shape best practice and optimize #care in #diabetes management. https://t.co/YHUajK611L This call for applications will close on 22 September 2023.

    • 📢Open Call - EASD's Guidelines Oversight Committee (GOC) calls for Evidence Synthesis Teams with expertise in systematic reviews, meta-analyses, and evidence syntheses in the field of #diabetes 👉https://t.co/YHUajK611L #guidelines #diabetescare @RichardIGHolt @atsapas

  • Mashup Score: 0

    Background: Although statins are a class I recommendation for prevention of atherosclerotic cardiovascular disease and its complications, their use is suboptimal. Differential underuse may mediate disparities in cardiovascular health for systematically marginalized persons. Objective: To estimate disparities in statin use by race–ethnicity–gender and to determine whether these potential disparities are explained by medical appropriateness of therapy and structural factors. Design: Cross-sectional analysis. Setting: National Health and Nutrition Examination Survey from 2015 to 2020. Participants: Persons eligible for statin therapy based on 2013 and 2018 American College of Cardiology/American Heart Association blood cholesterol guidelines. Measurements: The independent variable was race–ethnicity–gender. The outcome of interest was use of a statin. Using the Institute of Medicine framework for examining unequal treatment, we calculated adjusted prevalence ratios (aPRs) to estimate disp

    Tweet Tweets with this article
    • .@NIH-funded study shows that #disparities in #statin use for several race–ethnicity–gender groups are not explained by measurable differences in medical appropriateness of therapy, access to health care, and #SES. #NHANES #guidelines @NIDDKgov @NIH_NHLBI https://t.co/dwlipgtm3I https://t.co/WeySqhh8HF

  • Mashup Score: 0
    Guidelines - 10 month(s) ago

    © British Society for Haematology 2023 The British Society for Haematology is registered in England and Wales as a Company Limited by Guarantee, No 02645706 and as a Charity, No 1005735 Registered Office and correspondence address: 100 White Lion Street London N1 9PF. Phone: 020 7713 0990 Terms Processing Notice …

    Tweet Tweets with this article
    • Take a look at our latest guidelines which are designed to help all in the field of haematology https://t.co/86UEuHvZIf #BSH #guidelines #goodpractice https://t.co/3aijGOGLyh

  • Mashup Score: 0

    Read articles that appeared in the print edition of Healio Rheumatology. Healio is your trusted source for rheumatology news.

    Tweet Tweets with this article
    • Take a #MedicalMinute ⏱️ @LCalabreseDO breaks down the new @ACRheum @AAHKS #guidelines. Bottom line: Patients with moderate/severe #osteoarthritis shouldn’t delay hip or knee #arthroplasty – “better to get this done now and be healthy” https://t.co/RkIQx7BtiC #RheumTwitter https://t.co/zYM9abenSI